All News

Gene Therapy

Increasing Advanced Therapies’ Connectivity and Speed to Market Through Partnership
3 February 2023
Increasing Advanced Therapies’ Connectivity and Speed to Market Through Partnership
Jeff Buck, Vice President, Adherence
Navigating the Applications of Title21’s Manufacturing Execution System
3 February 2023
Navigating the Applications of Title21’s Manufacturing Execution System
In this Tech Demo, Title21
ScaleReady Demonstrate Cue – A Platform for Small Volume Cell Processing
2 February 2023
ScaleReady Demonstrate Cue – A Platform for Small Volume Cell Processing
In this Tech Demo we
MicrofluidX Demonstrate The Cyto Engine
2 February 2023
MicrofluidX Demonstrate The Cyto Engine
In this Tech Demo, James
POPULAR NEWS ITEMS
Image
3 February 2023

Navigating the Applications of Title21’s Manufacturing Execution System

Image
2 February 2023

ScaleReady Demonstrate Cue – A Platform for Small Volume Cell Processing

Image
1 February 2023

NICE Approves CAR-T as NHS Treatment for Aggressive Forms of Blood Cancer

Demonstrating Azenta’s Cryo Store Pico<sup>TM</sup>
25 January 2023
Demonstrating Azenta’s Cryo Store PicoTM
In this Tech Demo, Erica
Advanced Therapies Award Winners Announced, with Special Dedications
23 January 2023
Advanced Therapies Award Winners Announced, with Special Dedications
The inaugural, annual Advanced Therapies
Top 10 Events in Cell & Gene Therapy 2022
18 January 2023
Top 10 Events in Cell & Gene Therapy 2022
It’s day 1 of Advanced
Advanced Therapies Week Superplenary: CGT – A Supercharged Industry
17 January 2023
Advanced Therapies Week Superplenary: CGT – A Supercharged Industry
It’s that time of year
Load more News
RECOMENDED TOPICS
Allogeneic
Autologous
CAR-X
Cell Therapy
Cell-Based IO
Gene Editing
Gene Therapy
NKx
Stem Cells
Tissue Engineering
Viral/Non-Viral Vectors
POPULAR NEWS ITEMS
Image

Navigating the Applications of Title21’s Manufacturing Execution System

Image

ScaleReady Demonstrate Cue – A Platform for Small Volume Cell Processing

Image

NICE Approves CAR-T as NHS Treatment for Aggressive Forms of Blood Cancer